Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Rendell

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Cancer Research|September 18, 2016
Commentary on Almassalha et al., "The Greater Genomic Landscape: The Heterogeneous Evolution of Cancer"Henry T Lynch, Marc Rendell, Trudy G Shaw, et al.
Cutis|August 1, 2008
Ethical challenges of pregnancy prevention programsRobert Bonebrake, Murray J Casey, Christopher Huerter, et al.
International Journal of Dermatology|April 2, 2008
Skin blood flow in necrobiosis lipoidica diabeticorumBinh Ngo, Greg Wigington, Kristie Hayes, et al.
Journal of Diabetes Science and Technology|April 27, 2016
Long-Term Performance of Point-of-Care Hemoglobin A1c AssaysSujaytha Paknikar, Rohan Sarmah, Losika Sivaganeshan, et al.
Diabetes Care|March 28, 2008
Adjust to target in type 2 diabetes: comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisineRichard M Bergenstal, Mary Johnson, Margaret A Powers, et al.
Diabetes Research and Clinical Practice|March 12, 2017
Albiglutide for the treatment of type 2 diabetes mellitus: An integrated safety analysis of the HARMONY phase 3 trialsBo Ahrén, Molly C Carr, Karen Murphy, et al.
Journal of Diabetes Science and Technology|April 10, 2013
Improved quality of life in unselected insulin pump-treated children with type 1 diabetes in Eastern NebraskaSara Rendell, Omofosolade Kosoko-Lasaki, Greg Penny, et al.
Clinical Therapeutics|July 22, 2008
Safety profile and metabolic effects of 14 days of treatment with DIO-902: results of a phase IIa multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in patients with type 2 diabetes mellitusSherwyn L Schwartz, Marc Rendell, Andrew J Ahmann, et al.
Journal of Medical Systems|November 26, 2010
A 21 CFR Part 11 compliant graphically based electronic system for clinical research documentationAshley Bansal, Richard Chamberlain, Sean Karr, et al.
Diabetes Care|October 29, 2002
A comparison of the effects of rosiglitazone and glyburide on cardiovascular function and glycemic control in patients with type 2 diabetesMartin St John Sutton, Marc Rendell, Paresh Dandona, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Cancer Research|September 18, 2016
Commentary on Almassalha et al., "The Greater Genomic Landscape: The Heterogeneous Evolution of Cancer"Henry T Lynch, Marc Rendell, Trudy G Shaw, et al.
Cutis|August 1, 2008
Ethical challenges of pregnancy prevention programsRobert Bonebrake, Murray J Casey, Christopher Huerter, et al.
International Journal of Dermatology|April 2, 2008
Skin blood flow in necrobiosis lipoidica diabeticorumBinh Ngo, Greg Wigington, Kristie Hayes, et al.
Journal of Diabetes Science and Technology|April 27, 2016
Long-Term Performance of Point-of-Care Hemoglobin A1c AssaysSujaytha Paknikar, Rohan Sarmah, Losika Sivaganeshan, et al.
Diabetes Care|March 28, 2008
Adjust to target in type 2 diabetes: comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisineRichard M Bergenstal, Mary Johnson, Margaret A Powers, et al.
Diabetes Research and Clinical Practice|March 12, 2017
Albiglutide for the treatment of type 2 diabetes mellitus: An integrated safety analysis of the HARMONY phase 3 trialsBo Ahrén, Molly C Carr, Karen Murphy, et al.
Journal of Diabetes Science and Technology|April 10, 2013
Improved quality of life in unselected insulin pump-treated children with type 1 diabetes in Eastern NebraskaSara Rendell, Omofosolade Kosoko-Lasaki, Greg Penny, et al.
Clinical Therapeutics|July 22, 2008
Safety profile and metabolic effects of 14 days of treatment with DIO-902: results of a phase IIa multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in patients with type 2 diabetes mellitusSherwyn L Schwartz, Marc Rendell, Andrew J Ahmann, et al.
Journal of Medical Systems|November 26, 2010
A 21 CFR Part 11 compliant graphically based electronic system for clinical research documentationAshley Bansal, Richard Chamberlain, Sean Karr, et al.
Diabetes Care|October 29, 2002
A comparison of the effects of rosiglitazone and glyburide on cardiovascular function and glycemic control in patients with type 2 diabetesMartin St John Sutton, Marc Rendell, Paresh Dandona, et al.
Pageof 5